About Lpath
Lpath was a Healthcare company based in San Diego (United States) founded in 1997. It specializes in treating and diagnosing human diseases using bioactive signaling lipids as targets. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Drug Development and Lipid-based Therapies. Its legal entity is LPATH, INC. Its competitors include BeiGene, Moderna and Incyte; 2 of its 3 listed competitors have raised funding.
Company details
Lpath, backed by 28664440.0 from HHS, focuses on providing healthcare solutions, advancing biotech innovations, drug development, and lipid-based therapies. Specializes in treating and diagnosing human diseases using bioactive signaling lipids as targets. Driving innovation, growth, and excellence in its industry sectors.
- Annual Revenue$1.6 M (USD)as on Dec 31, 2015
- Latest Funding Round$1.45M (USD), Grant
Apr 2016
- Investors
Funding Insights of Lpath
- Total Rounds 13
- Last Round Grant — $1.45M
- First Round $3M
(Sep 2004)
- Investors Count 1
Latest 10 of 13 funding rounds of Lpath with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2016 | $1.45M | Grant | – | – | |
| Oct 2014 | $12.53M | Post-IPO | – | – | – |
| May 2014 | $223,988 | Grant | – | – | |
| Sep 2013 | $145,230 | Grant | – | – | |
| Nov 2010 | $4.9M | Post-IPO | – | – | – |
| Jul 2010 | $3M | Grant | – | – | |
| Sep 2009 | $292,247 | Grant | – | – | |
| Aug 2009 | $152,724 | Grant | – | – | |
| Aug 2009 | $139,523 | Grant | – | – | |
| May 2009 | $3M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Lpath
Lpath has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Lpath
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Lpath
4 dated milestones of Lpath across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Lpath is founded.
- Funding First funding round of $3.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Grant, of $1.4M.
Competitors of Lpath
Lpath has 3 listed competitors in our database, 2 of them funded. They include BeiGene, Moderna and Incyte.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| beigene.com | 2010 | Cambridge, United States | $172M | 1,090 | Targeted and immune-oncology drugs for cancer treatment are developed. | |
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| incyte.com | 1991 | Wilmington, United States | 1,387 | Small molecules are developed for cancer and skin disease treatments. |
Detailed competitors of Lpath
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lpath
Websites that share an audience with Lpath (lpath.com).
Websites whose visitors overlap most with Lpath. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| alimerasciences.com | 63% | View details | |||
| soligenix.com | 57% | 12K | #2,294,239 | View details |
Top companies in Cell Therapy
3 companies that operate in the same segment as Lpath (Cell Therapy) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | 520 | ||
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lpath
Complete news archive for Lpath
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lpath
Lpath was founded in 1997 and raised its 1st funding round 7 years after it was founded.
Lpath is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Annual revenue of Lpath is $1.6M as on Dec 31, 2015.
Lpath, backed by 28664440.0 from HHS, focuses on providing healthcare solutions, advancing biotech innovations, drug development, and lipid-based therapies. Specializes in treating and diagnosing human diseases using bioactive signaling lipids as targets. Driving innovation, growth, and excellence in its industry sectors.
Lpath has 1 investor. Key investors include HHS.
Lpath operates through Lpath, Inc.